(Luitpold) Adequan Canine is administered by intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. Adequan Canine contains polysulfated glycosaminoglycan (PSGAG). Polysulfated glycosaminoglycan is characterized as a "disease modifying osteoarthritis drug." Adequan Canine contains 100 mg/ml of polysulfated glycosaminoglycan . The recommended dose of Adequan Canine is 2 mg/lb body weight (.02 mL/lb), by intramuscular injection only, twice weekly for up to 4 weeks. Polysulfated glycosaminoglycan.
Press Release from Luitpold